Eurofarma recognized once again among the best by the 2025 GPTW™ Health Ranking
São Paulo, July 29, 2025 – Eurofarma, recognized for more than 20 years as one of the Best Companies to Work for in Brazil, once again stood out among the GPTW™ 2025 Best Companies to Work For—this time in the Healthcare ranking, promoted by Great Place to Work®. The in-person ceremony took place on Monday, July 28, at Bisutti Boulevard JK, in São Paulo.
Among pharmaceutical companies, Eurofarma ranked 70th, once again earning the seal that recognizes companies that promote relevant initiatives for employees’ health, while also reaffirming its commitment to inclusive, sustainable, and people-centered practices.
In 2025, Eurofarma has already been recognized in several GPTW™ rankings in Brazil and internationally, for example:
Recognition in the GPTW Diversity ranking in Brazil;
Presence in GPTW Paraguay, where we celebrated 2nd place in the national ranking and also 2nd place in the thematic ranking Innovative Culture;
Highlight in the GPTW Bolivia ranking, being listed in our first participation;
A strong 3rd place in GPTW Peru, in addition to being listed in the thematic ranking Women.
These achievements reflect Eurofarma’s global commitment to fostering respectful, collaborative workplaces focused on human development. All of these recognitions are directly connected to the Eurofarma Way of Being, which represents the essence of our organizational culture. In an environment where we value diversity of origins, races, languages, and beliefs, we promote unity around a common purpose and strong values.
About Eurofarma
Founded in 1972, Eurofarma operates in the healthcare sector through the production and commercialization of products and services that improve people’s quality of life. Focused on generating shared value, it covers the main pharmaceutical segments, such as prescription medicines, OTC and personal care, generics, hospital, oncology, and animal health, in addition to providing third-party manufacturing services. With broad coverage across therapeutic classes, the portfolio includes more than 4,000 SKUs, serving the leading medical specialties. A leader in medical prescriptions in Brazil—where it holds the #2 position in generics—Eurofarma is present in 24 countries, with full coverage across Latin America and operations in the U.S. and Africa. It has 13,300 employees and 11 plants, with total production of 600 million units in 2024. That same year, it invested more than R$ 800 million in innovation projects and reached total net revenue of R$ 11 billion.
Eurofarma on social media
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarma | YouTube: @eurofarmalab